You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia or Myelodysplastic Syndromes (MDS) in aplasia

Showing 1 - 25 of 7,668
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)

Recruiting
  • Acute Leukemia
  • +24 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 4, 2021

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • description of MDS pzatient cohort
  • Brest, France
    Chu Brest
Oct 27, 2022

MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • IFN-γ (interferon gamma-1b) injection
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 5, 2023

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

MDS, Chronic Myelomonocytic Leukemia-2, Secondary Acute Myeloid Leukemia Trial in Nanjing (unrelated umbilical cord blood)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • unrelated umbilical cord blood
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Oct 16, 2022

MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 2, 2022

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

Anemia, MDS, Chronic Myelomonocytic Leukemia Trial in France, United States (Sotatercept)

Completed
Has Results
  • Anemia
  • +5 more
  • Denver, Colorado
  • +19 more
Oct 20, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Leukemia, Relapsed, Myeloid Trial in Netherlands, Switzerland (MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123

Recruiting
  • Leukemia
  • +3 more
  • MP0533 (multispecific DARPin CD3 Engager Targeting CD33, CD123 and CD70)
  • Amsterdam, Netherlands
  • +4 more
Jan 4, 2023

Acute Myeloid Leukemia, MDS Trial in Hangzhou (Decitabine for Injection, VENCLYXTO)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Sep 18, 2023

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 31, 2023

Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan

Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • Fludarabine and Busulfan
  • Fludarabine and Melphalan
  • Wuhan, Hubei, China
    Wuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023

Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

Available
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Galinpepimut-S
  • (no location specified)
Oct 20, 2022

Refractory Acute Myeloid Leukemia, Relapsed Acute Myelomonocytic Leukemia, MDS Trial in Cleveland (CPX-351)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Mar 15, 2022

MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,

Recruiting
  • Myelodysplastic Syndromes
  • Secondary Acute Myeloid Leukemia
  • CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
  • Standard of Care Chemotherapy
  • Tampa, Florida
    Moffitt Cancer Center
Sep 27, 2022

MDS Trial (Imetelstat)

Available
  • Myelodysplastic Syndromes
  • (no location specified)
Jun 30, 2023

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022